At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are, allowing you to thrive both personally and professionally. This is how we aim to prevent, stop and cure diseases and ensure everyone has access to healthcare today and for generations to come. Join Roche, where every voice matters.
The Position
In Roche’s Pharmaceutical Research and Early Development Organisation (pRED), we make transformative medicines for patients in order to tackle some of the world’s toughest unmet healthcare needs. At pRED, we are united by our mission to transform science into medicine. Together, we create a culture defined by curiosity, responsibility, and humility, where our talented people are empowered and inspired to bring forward extraordinary life-changing innovation at speed.
This position is located in PASS-Pathology and Applied Safety Sciences, a department within the Pharmaceutical Sciences function. We drive the non-clinical safety assessment of drug candidates from small molecules to complex biological products during the discovery and development phases at Roche.
Job Mission
We are offering an exceptional opportunity for a student researcher to contribute to our mission of transforming the traditional drug discovery process by advancing more predictive human model systems. Your role is to be involved in the final development and validation of an in vitro assay for developmental toxicity testing. We are seeking a motivated, detail-oriented student researcher eager to contribute to a groundbreaking project with significant health implications. If you are passionate about pioneering research and driven to make a meaningful impact in the field of developmental toxicity research, we invite you to join us in this exciting endeavor.
Your impact
-
Supports the development of safer pharmaceuticals by implementing and validating novel assays for in vitro teratogenicity testing.
-
Employs cutting-edge methodologies to create and standardize in vitro models for assessing potential teratogenic effects of new drugs.
-
Aims to improve early detection of developmental toxicity and enhance the predictability of teratogenic risks in drug candidates.
Your profile
As an intern conducting research in our lab, you thrive in environments that encourage autonomy and highly value unique contributions to collaborative projects. You are adaptable and creative in problem-solving, capable of navigating research challenges effectively. You work well in a team, embracing an inclusive approach that leverages diverse perspectives. You are dedicated to fostering a supportive atmosphere, engaging in active knowledge exchange, and pursuing continuous learning. Your commitment to these principles will be crucial for your success and the advancement of our collective scientific goals.
-
You have experience in cell culture, preferably with pluripotent cells. Prior work with hiPSC culture and stem cell research is highly desirable.
-
You are currently enrolled in a M.Sc. or in a PhD program in relevant fields such as Biology or Bioengineering, with a focus on cellular and molecular biology, or you have completed your M.Sc. degree within the past 12 months.
-
You have hands-on experience working with flow cytometry and/or microscopy
-
You have strong analytical and problem-solving skills to address complex scientific questions and challenges in the field of stem cell research
-
You show meticulous attention to detail to ensure the accuracy and quality of research outputs.
-
You have scientific curiosity as well as effective communication and documentation skills in English.
-
You are self-motivated and driven to contribute to transformative projects with the potential for significant health implications.
-
You have the ability to work effectively in a collaborative environment, contributing to a team's success while advancing independent research goals.
Due to Swiss regulations: Non-EU/EFTA citizens must provide a letter from the university stating that an internship is mandatory for the studies and specifying the required length of the internship. Please upload this letter, along with your enrollment certificate, CV, and motivation letter.
Planned Start Date: As soon as possible
Workload: 100%
Duration: 9 months
The internship is not suitable for writing a Bachelor’s/ Master’s Thesis.
Application
Your complete application includes the following documents:
-
A current CV and a Motivation Letter
-
A certificate of enrollment (if you are currently studying)
We look forward to receiving your application!
Who we are
A healthier future drives us to innovate. Together, more than 100’000 employees across the globe are dedicated to advance science, ensuring everyone has access to healthcare today and for generations to come. Our efforts result in more than 26 million people treated with our medicines and over 30 billion tests conducted using our Diagnostics products. We empower each other to explore new possibilities, foster creativity, and keep our ambitions high, so we can deliver life-changing healthcare solutions that make a global impact.
Let’s build a healthier future, together.
Basel is the headquarters of the Roche Group and one of its most important centres of pharmaceutical research. Over 10,700 employees from over 100 countries come together at our Basel/Kaiseraugst site, which is one of Roche`s largest sites. Read more.
Besides extensive development and training opportunities, we offer flexible working options, 18 weeks of maternity leave and 10 weeks of gender independent partnership leave. Our employees also benefit from multiple services on site such as child-care facilities, medical services, restaurants and cafeterias, as well as various employee events.
Roche is an Equal Opportunity Employer.
Top Skills
What We Do
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).